News Search Year - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 Archive May 8, 2023 Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference Archive May 3, 2023 Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results Archive April 26, 2023 Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023 Archive April 19, 2023 Deciphera Pharmaceuticals to Present at the Stifel Virtual Targeted Oncology Days Archive March 14, 2023 Deciphera Pharmaceuticals Announces QINLOCK® Included in NCCN Guidelines® for the Treatment of Second-Line GIST Patients and FDA Grants Breakthrough Therapy Designation for QINLOCK in Second-Line GIST Patients with Mutations in KIT Exon 11 and 17/18 Archive March 14, 2023 Deciphera Pharmaceuticals Announces Eight Presentations Highlighting Discovery Research Programs at the American Association for Cancer Research (AACR) Annual Meeting 2023 Archive March 1, 2023 Deciphera Pharmaceuticals Announces Completion of Enrollment for Pivotal Phase 3 MOTION Study of Vimseltinib in TGCT Archive February 27, 2023 Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences Archive February 7, 2023 Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results Archive February 2, 2023 Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
Archive May 8, 2023 Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
Archive April 26, 2023 Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023
Archive April 19, 2023 Deciphera Pharmaceuticals to Present at the Stifel Virtual Targeted Oncology Days
Archive March 14, 2023 Deciphera Pharmaceuticals Announces QINLOCK® Included in NCCN Guidelines® for the Treatment of Second-Line GIST Patients and FDA Grants Breakthrough Therapy Designation for QINLOCK in Second-Line GIST Patients with Mutations in KIT Exon 11 and 17/18
Archive March 14, 2023 Deciphera Pharmaceuticals Announces Eight Presentations Highlighting Discovery Research Programs at the American Association for Cancer Research (AACR) Annual Meeting 2023
Archive March 1, 2023 Deciphera Pharmaceuticals Announces Completion of Enrollment for Pivotal Phase 3 MOTION Study of Vimseltinib in TGCT
Archive February 7, 2023 Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results
